JPH0448775B2 - - Google Patents
Info
- Publication number
- JPH0448775B2 JPH0448775B2 JP55086675A JP8667580A JPH0448775B2 JP H0448775 B2 JPH0448775 B2 JP H0448775B2 JP 55086675 A JP55086675 A JP 55086675A JP 8667580 A JP8667580 A JP 8667580A JP H0448775 B2 JPH0448775 B2 JP H0448775B2
- Authority
- JP
- Japan
- Prior art keywords
- compound
- parasites
- animal
- dimethylformamide
- warm
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 241001465754 Metazoa Species 0.000 claims description 29
- 150000001875 compounds Chemical class 0.000 claims description 27
- 238000000034 method Methods 0.000 claims description 25
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 claims description 24
- 239000000203 mixture Substances 0.000 claims description 16
- 244000045947 parasite Species 0.000 claims description 12
- 230000037396 body weight Effects 0.000 claims description 7
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 claims description 4
- -1 α-cyano-3-phenoxybenzyl Chemical group 0.000 claims description 4
- CYCYDSJDZNVSPP-OVEKKEMJSA-N (1r,3s)-3-(1,2-dibromo-2,2-dichloroethyl)-2,2-dimethylcyclopropane-1-carboxylic acid Chemical compound CC1(C)[C@@H](C(Br)C(Cl)(Cl)Br)[C@H]1C(O)=O CYCYDSJDZNVSPP-OVEKKEMJSA-N 0.000 claims description 2
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical group [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 claims description 2
- FXHOOIRPVKKKFG-UHFFFAOYSA-N N,N-Dimethylacetamide Chemical compound CN(C)C(C)=O FXHOOIRPVKKKFG-UHFFFAOYSA-N 0.000 claims description 2
- 239000004480 active ingredient Substances 0.000 claims description 2
- 229910052801 chlorine Inorganic materials 0.000 claims description 2
- 239000000460 chlorine Substances 0.000 claims description 2
- 125000001309 chloro group Chemical group Cl* 0.000 claims description 2
- 235000015112 vegetable and seed oil Nutrition 0.000 claims description 2
- 239000008158 vegetable oil Substances 0.000 claims description 2
- YMGUBTXCNDTFJI-UHFFFAOYSA-N cyclopropanecarboxylic acid Chemical compound OC(=O)C1CC1 YMGUBTXCNDTFJI-UHFFFAOYSA-N 0.000 claims 1
- 239000000126 substance Substances 0.000 claims 1
- 229940126062 Compound A Drugs 0.000 description 15
- NLDMNSXOCDLTTB-UHFFFAOYSA-N Heterophylliin A Natural products O1C2COC(=O)C3=CC(O)=C(O)C(O)=C3C3=C(O)C(O)=C(O)C=C3C(=O)OC2C(OC(=O)C=2C=C(O)C(O)=C(O)C=2)C(O)C1OC(=O)C1=CC(O)=C(O)C(O)=C1 NLDMNSXOCDLTTB-UHFFFAOYSA-N 0.000 description 15
- 241000238876 Acari Species 0.000 description 13
- 230000000694 effects Effects 0.000 description 8
- 238000011282 treatment Methods 0.000 description 7
- 238000012360 testing method Methods 0.000 description 5
- 241000403354 Microplus Species 0.000 description 4
- 239000003981 vehicle Substances 0.000 description 4
- 241000283690 Bos taurus Species 0.000 description 3
- 244000309464 bull Species 0.000 description 3
- 239000004006 olive oil Substances 0.000 description 3
- 235000008390 olive oil Nutrition 0.000 description 3
- 241000864202 Rhipicephalus evertsi Species 0.000 description 2
- 241000238680 Rhipicephalus microplus Species 0.000 description 2
- 239000013543 active substance Substances 0.000 description 2
- 239000003995 emulsifying agent Substances 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 230000002496 gastric effect Effects 0.000 description 2
- 238000007911 parenteral administration Methods 0.000 description 2
- 239000004540 pour-on Substances 0.000 description 2
- 241000894007 species Species 0.000 description 2
- 239000004094 surface-active agent Substances 0.000 description 2
- 230000001839 systemic circulation Effects 0.000 description 2
- VSBCUTLTLUSECJ-OVEKKEMJSA-N (1R)-cis-2,2-dimethyl-3-(1,2,2,2-tetrabromoethyl)cyclopropanecarboxylic acid Chemical compound CC1(C)[C@@H](C(Br)C(Br)(Br)Br)[C@H]1C(O)=O VSBCUTLTLUSECJ-OVEKKEMJSA-N 0.000 description 1
- 206010063409 Acarodermatitis Diseases 0.000 description 1
- 241000238679 Amblyomma Species 0.000 description 1
- 244000272765 Elaeocarpus serratus Species 0.000 description 1
- 208000018522 Gastrointestinal disease Diseases 0.000 description 1
- 241001480803 Hyalomma Species 0.000 description 1
- 235000019483 Peanut oil Nutrition 0.000 description 1
- 241001494479 Pecora Species 0.000 description 1
- 241001481704 Rhipicephalus appendiculatus Species 0.000 description 1
- 241001251773 Rhipicephalus simus Species 0.000 description 1
- 241000447727 Scabies Species 0.000 description 1
- 241000282887 Suidae Species 0.000 description 1
- 230000000895 acaricidal effect Effects 0.000 description 1
- 244000309466 calf Species 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 150000002170 ethers Chemical class 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 230000000855 fungicidal effect Effects 0.000 description 1
- 244000144980 herd Species 0.000 description 1
- 230000000749 insecticidal effect Effects 0.000 description 1
- 244000144972 livestock Species 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 230000001069 nematicidal effect Effects 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 235000019198 oils Nutrition 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 239000000312 peanut oil Substances 0.000 description 1
- 230000000361 pesticidal effect Effects 0.000 description 1
- 229920000151 polyglycol Polymers 0.000 description 1
- 239000010695 polyglycol Substances 0.000 description 1
- 208000005687 scabies Diseases 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 238000011200 topical administration Methods 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N53/00—Biocides, pest repellants or attractants, or plant growth regulators containing cyclopropane carboxylic acids or derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Emergency Medicine (AREA)
- Plant Pathology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Agronomy & Crop Science (AREA)
- Pest Control & Pesticides (AREA)
- Dermatology (AREA)
- Dentistry (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Environmental Sciences (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Description
本発明の主題は、寄生虫のたかつた温血動物の
全身から寄生虫を駆除するために動物を処置する
にあたり、処置すべき動物の体の一部に、好まし
くは動物の背部の一部に、次式(IA)
(ここでXは塩素又は臭素原子を表わす)
に相当する全ての可能な異性体形態にある化合物
の少なくとも1種を活性成分として、動物の処置
を可能にさせる適当なビヒクル中に含有する組成
物の有効量を投与することからなり、そして使用
する活性化合物の量を体重1Kg当り0.5〜10mgと
することを特徴とする、寄生虫がたかつた温血動
物の処置方法にある。
式IAの化合物は、ベルギー国特許第859894号及
び同873201号に記載の方法によつて製造すること
のできる既知の化合物である。
式IAの化合物は、顕著なペスチサイド性、特に
優れた殺虫性、殺だに性、殺線虫性及び殺菌性を
示す。
これまでのところ、式IAの化合物を温血動物の
寄生虫の駆除に使用するために知られている投与
方法は、経消化器、非経口的又は局所投与の方法
であり、しかしてこれらに応じた組成物が知られ
いるだけであつた。
ここに、「ポアオン(pour on)」法と呼ばれる
方法で式IAの化合物を投与することによつて動物
の寄生虫の駆除に優れた結果が得られることが発
見された。
この方法が動物の体の小さい表面、好ましくは
背中に活性物質の含有する溶液を塗布してこの活
性物質を動物の全身的循環に通入させ、そして動
物の全身に対する効果を得ることなることは知ら
れている。
もちろん、この方法は一般的ではない。これ
は、皮膚層を通過でき且つその活性を保ちなが
ら、即ち分解したり又はそれ自体活性な代謝産物
に分解することなく全身的循環に流入できるよう
な化合物に対してのみ適用できるにすぎないから
である。
従来技術のいずれもこのような方法による式IA
の化合物の使用を示唆していない。
本発明によれば、式IAの化合物を「ポアオン」
法によつて適用することができ、したがつてこの
方法は予期できなかつた特色を提供する。
さらに、本発明の方法は、商業的規模で大きな
利益を提供する。なぜならば、それは、実験の部
でさらに示す試験結果により明示されるように、
優秀な結果を非常に少量の式IAの化合物により非
常に早く且つ持続して得ることができるからであ
る。
本発明に従う方法は、式IAの化合物の簡単で清
潔で且つ経済的な適用を可能にさせる。標準な方
法と比較したときのその利点は、専門家には明ら
かであろう。
消化器経路での投与は、良好な結果を与える
が、胃腸障害が生じ得るのでできれば避けるべき
であり、そして特に胃に住みついた寄生虫の駆除
のために保留すべきである。
また、「薬浴」による投与は、全く良好な結果
を与える。しかし、不幸にも、これは全く多量の
化合物を必要とする。なぜならば、ピレスリノイ
ドは一般的にいつて容易に分解するので浴を更新
する必要があるからである。
また、非経口的投与もできれば避けるべきであ
る。なぜならば、群をなす動物の全部に注射する
ことは容易ではないからである。
本発明に従う方法は、温血動物の全てに、特に
家畜、例えば牛、羊又は豚などに適用することが
できる。
下記の実験の部は、牛について得られた結果を
明示している。
本発明に従う方法は、寄生虫が内部又は外部寄
生虫であつてもそれらを駆除することができる。
特に、それらは、だに類、蠕虫、ウジ及び各種の
刺しばえの駆除を可能にさせる。
しかして、本発明の方法は、だに類、特にだに
や、疥癬虫などを駆除するのに用いられる。
特に、本発明の方法で使用される組成物は、獣
医学用組成物の形で提供される。
本発明に従う次式IAの化合物のうちでは下記の
ものがあげられる。
(1R,cis)−2,2−ジメチル−3−(2,2
−ジクロル−1,2−ジブロムエチル)シクロプ
ロパン−1−カルボン酸(S)α−シアノ−3−
フエノキシベンジル、
(1R,cis)−2,2−ジメチル−3−(1,
2,2,2−テトラブロムエチル)シクロプロパ
ン−1−カルボン酸(S)−α−シアノ−3−フ
エノキシベンジル。
上記の化合物(その最初のものを以下では化合
物Aという)は、ベルギー国特許第858894号の例
1及び2に記載の方法によつて製造することがで
きる。
式IAの化合物の使用量は、処理すべき動物の状
態、種族、環境並びに所望する結果によつて変
る。
それは、一般に処理する動物の体重1Kgにつき
0.5〜10mgの式IAの化合物である。
また、実施すべき処理の回数も、化合物の投与
量を決定するものとして上述したのと同じパラメ
ータによつて変る。
しかしながら、下記する実験は、1回の適用で
優秀な結果が得られることを示している。
前述したように、本発明に従う方法で適用され
る組成物は、皮膚層を通過できるようなビヒクル
を含有する。
ここで、皮膚層を通過できるようなビヒクルと
は、ジメチルホルムアミド、ジメチルスルホキシ
ド又はジメチルアセトアミドのような分散性化合
物或いは式IAの化合物の溶解度を許す限りは製薬
工業で知られた皮膚層の通過を容易にさせる全て
の薬剤を含有する溶液、特に油状溶液であると解
されたい。用いられる油状溶液は、好ましくはオ
リーブ油又は落花生油のような植物油を含有す
る。
特に、本発明の主題は、ビヒクルがジメチルホ
ルムアミドの油状溶液であることを特徴とする方
法にある。
さらに、本発明に従う組成物は、乳化剤或いは
表面活性剤も含有できる。
下記の例は本発明を例示するが、これを何ら制
限するものではない。
例 1
ブーフイラス・ミクロプラス
(Boophilusmicroplus)に対する試験
体重340gの若い雄牛にブーフイラス・ミクロ
プラス種のだにを故意にたからせる。
だには発育の全ての段階にある。処理動物の体
重1Kgにつき5mgの化合物Aをジメチルホルムア
ミドとオリーブ油との混合物(1:1)中に溶液
状で含有する溶液を所定の日(D)に動物の背中に塗
布する。80mlの油状溶液として1.7gの化合物A
を用いる。
だにを数え、そして発育段階を観察する。
The subject of the invention provides a method for treating a warm-blooded animal infested with parasites in order to eliminate parasites from the whole body of the animal, preferably in a part of the animal's body to be treated, preferably in a part of the back of the animal. Then, the following formula (I A ) (wherein X represents a chlorine or bromine atom) A composition containing as active ingredient at least one compound in all possible isomeric forms corresponding to A method for the treatment of warm-blooded animals infested with parasites, characterized in that the amount of active compound used is from 0.5 to 10 mg/kg body weight. The compound of formula I A is a known compound which can be prepared by the method described in Belgian Patents Nos. 859,894 and 873,201. The compounds of formula I A exhibit pronounced pesticidal properties, in particular good insecticidal, acaricidal, nematocidal and fungicidal properties. So far, the methods of administration known for the use of compounds of formula I A for the control of parasites in warm-blooded animals are gastrointestinal, parenteral or topical administration; The only known compositions were the following. It has now been discovered that excellent results are obtained in the control of parasites in animals by administering compounds of formula IA in a manner referred to as the "pour on" method. The method involves applying a solution containing the active substance to a small surface of the animal's body, preferably the back, allowing this active substance to pass into the animal's systemic circulation and obtaining an effect on the whole body of the animal. Are known. Of course, this method is not common. This is only applicable to compounds that can pass through the skin layers and enter the systemic circulation while retaining their activity, i.e. without being degraded or broken down into active metabolites themselves. It is. None of the prior art methods use formula I A
does not suggest the use of compounds. According to the invention, a compound of formula I A can be used as a "pour-on"
This method therefore offers unexpected features. Furthermore, the method of the invention provides significant benefits on a commercial scale. Because, as evidenced by the test results further presented in the experimental part,
This is because excellent results can be obtained very quickly and sustainably with very small amounts of the compound of formula IA . The method according to the invention allows a simple, clean and economical application of compounds of formula I A. Its advantages when compared to standard methods will be clear to the expert. Administration by the gastrointestinal route, although giving good results, should be avoided if possible as gastrointestinal disturbances may occur and should be reserved especially for the extermination of parasites that have settled in the stomach. Also, administration by "bath" gives quite good results. Unfortunately, however, this requires quite large amounts of the compound. This is because pyrethrinoids generally burn and decompose easily, requiring the bath to be renewed. Parenteral administration should also be avoided if possible. This is because it is not easy to inject all animals in a herd. The method according to the invention can be applied to all warm-blooded animals, especially domestic animals such as cattle, sheep or pigs. The experimental section below specifies the results obtained on cows. The method according to the invention can eliminate parasites whether they are internal or external parasites.
In particular, they make it possible to control mites, worms, maggots and various stingers. Thus, the method of the invention can be used to control mites, especially mites, scabies, and the like. In particular, the compositions used in the methods of the invention are provided in the form of veterinary compositions. Among the compounds of formula I A according to the invention, mention may be made of the following: (1R,cis)-2,2-dimethyl-3-(2,2
-dichloro-1,2-dibromoethyl)cyclopropane-1-carboxylic acid (S) α-cyano-3-
Phenoxybenzyl, (1R, cis)-2,2-dimethyl-3-(1,
2,2,2-tetrabromoethyl)cyclopropane-1-carboxylic acid (S)-α-cyano-3-phenoxybenzyl. The abovementioned compounds (the first of which is referred to below as compound A) can be prepared by the method described in Examples 1 and 2 of Belgian Patent No. 858,894. The amount of compound of formula IA used will vary depending on the condition of the animal to be treated, the species, the environment and the desired result. It is generally calculated as follows:
0.5-10 mg of a compound of formula IA . The number of treatments to be performed also depends on the same parameters discussed above as determining the dosage of the compound. However, the experiments described below show that excellent results can be obtained with a single application. As mentioned above, the composition applied in the method according to the invention contains a vehicle that is capable of passing through the skin layers. Vehicles which are capable of passing through the skin layer include dispersible compounds such as dimethylformamide, dimethyl sulfoxide or dimethylacetamide, or any vehicle that can pass through the skin layer, as long as the solubility of the compound of formula I A is permitted. A solution, in particular an oily solution, is to be understood as a solution, especially an oily solution, containing all agents that facilitate the The oily solution used preferably contains vegetable oil, such as olive oil or peanut oil. In particular, the subject of the invention is a process characterized in that the vehicle is an oily solution of dimethylformamide. Furthermore, the composition according to the invention can also contain emulsifiers or surfactants. The following examples illustrate the invention without restricting it in any way. Example 1 Test against Boophilus microplus A young bull weighing 340 g is deliberately infested with ticks of the species Boophilus microplus. Dani are present at all stages of development. A solution containing 5 mg of compound A per kg of body weight of the treated animal in solution in a mixture of dimethylformamide and olive oil (1:1) is applied to the back of the animal on the indicated day (D). 1.7g Compound A as 80ml oily solution
Use. Count the ticks and observe their developmental stages.
【表】
結 論
化合物Aは顕著な活性を示す。
例 2
ブーフイラス・ミクロプラス(Mexico種)に
対する試験
ブーフイラス・ミクロプラスを故意にたからせ
た若い雄牛を用いる。対照バツチには何らの処理
もしない。
一のバツチに対して、処理動物の体重1Kgにつ
き5mgの化合物Aを含有する例1で用いたのと同
一の溶液100c.c.を所定の日(D)に塗布する。
だにを処理日の前後で数える。処理動物及び対
照動物上のだにの数を数える。
得られた結果は次の通りである。[Table] Conclusion Compound A shows remarkable activity. Example 2 Test against Boufilus microplus (Mexico variety) Young bulls intentionally infected with Boufilus microplus are used. Control batches receive no treatment. A batch is coated with 100 c.c. of the same solution as used in Example 1 containing 5 mg of Compound A per kg of body weight of treated animals on the indicated day (D). Count the ticks before and after the treatment date. Count the number of ticks on treated and control animals. The results obtained are as follows.
【表】【table】
【表】
結 論
化合物Aは顕著な活性を示す。
例 3
ブーフイラス・ミクロプラス(Mexico種)に
対する試験
8頭の若い雄牛に、ブーフイラス・ミクロプラ
ス(感受性Mexico種)の発育段階の全てが現わ
れるように、このだにの幼虫をたからせた。
化合物Aは、処理動物の体重1Kgにつき5mg、
2.5mg及び1mgの薬量で、85gのジメチルホルム
アミド、7gのエマルソゲン(Emulsogen)及
び3gのアルコパル(Arcopal)よりなる混合物
の溶液として、適用容積が40又は30c.c.であるよう
にして、投与した。Arcopalは、非イオン性アル
キルフエノールポリグリコールエーテルよりなる
表面活性剤である。Emulsogenは、油、パラフ
イン又は有機溶媒用の乳化剤である。
だにを処理日の前後で数え、そして処理動物上
のだにの数を対照動物上の数とを比較する。化合
物の活性(%)を決定する。
得られた結果は次の通りである。[Table] Conclusion Compound A shows remarkable activity. Example 3 Test against Boufuilus microplus (Mexico breed) Eight young bulls were infested with the larvae of this mite so that all developmental stages of Boufillus microplus (susceptible Mexico breed) were represented. Compound A was administered at a dose of 5 mg/kg of body weight of treated animals;
Administered as a solution of a mixture consisting of 85 g dimethylformamide, 7 g Emulsogen and 3 g Arcopal in doses of 2.5 mg and 1 mg, with an application volume of 40 or 30 c.c. did. Arcopal is a surfactant consisting of nonionic alkyl phenol polyglycol ethers. Emulsogen is an emulsifier for oils, paraffins or organic solvents. The ticks are counted before and after the treatment day and the number of ticks on treated animals is compared to the number on control animals. Determine the activity (%) of the compound. The results obtained are as follows.
【表】
5mg/Kg、2.5mg/Kg及び1mg/Kgの薬量では、
化合物Aの効能はそれぞれ99.4%、97.6%及び
94.3%と決定された。
結論:化合物Aは顕著な活性を示す。
例 4
リピセフアラス・アペンデイキユラタス、
(Rhipicephalus appendiculatus)、リピセフア
ラス・エベルトシ(Rhipicephalus evertsi)、
リピセフアラス・シマス(Rhipicephalus
simus)、アンブリオマ・ヘブラエーム
(Amblyomma habraeum)及びヒアロマ・ス
ペシーズ(Hyalomma species)に対する試験
化合物Aを処理動物の体重1Kgにつき5mg、
2.5mg及び1mg/Kgの薬量で投与した。
動物には数種のだに類が自然に大量にたかつて
いた。
処理してから1日、2日及び3日後に得らてた
結果を下記の表に要約する。[Table] At doses of 5mg/Kg, 2.5mg/Kg and 1mg/Kg,
The efficacy of compound A was 99.4%, 97.6% and
It was determined to be 94.3%. Conclusion: Compound A shows significant activity. Example 4 Lipicephalus appendeiquilatus,
(Rhipicephalus appendiculatus), Rhipicephalus evertsi (Rhipicephalus evertsi),
Rhipicephalus
simus), Amblyomma habraeum and Hyalomma species Compound A was administered at 5 mg per kg of body weight of treated animals;
It was administered in doses of 2.5 mg and 1 mg/Kg. The animals naturally had large numbers of several species of mites. The results obtained after 1, 2 and 3 days of treatment are summarized in the table below.
【表】
結 論:
数種の異なつただに類が自然にたかつた状態
で、化合物Aは顕著な活性を示す。
例 5
アフリカ産のだに類がたかつた家畜に対する試
験
雌の成牛及び約8ケ月の子牛を用いる。これら
の動物にはだに類がたかつている。
これらの動物をその体重1Kgにつき4mgから5
mg又は10mgの化合物Aを含有する溶液を用いて処
理する。
処理した日及びそれ以後だにを数える。
結果は次の通りである。[Table] Conclusion: Compound A exhibits remarkable activity in the natural state of several different mites. Example 5 Test on tick-infested livestock from Africa Adult female cows and calves approximately 8 months old are used. These animals have ticks. These animals should be treated with 4 to 5 mg per kg of body weight.
Treat with a solution containing 10 mg or 10 mg of compound A. Count the mites on the day of treatment and thereafter. The results are as follows.
【表】 結 論 化合物Aは顕著な活性を示す。 例 6 組成物の例 下記の処方に相当する組成物を調製した。 化合物A …1.7g ジメチルホルムアミド …40c.c. オリーブ油 …40c.c. 例 7 組成物の例 下記の処方に相当する組成物を調製した。 化合物A …1.6g ジメチルホルムアミド …85c.c. エマルゾゲン …7g アルコパル …3g【table】 Conclusion Compound A shows significant activity. Example 6 Examples of compositions A composition corresponding to the following formulation was prepared. Compound A...1.7g Dimethylformamide …40c.c. Olive oil…40c.c. Example 7 Examples of compositions A composition corresponding to the following formulation was prepared. Compound A...1.6g Dimethylformamide …85c.c. Emulzogen…7g Alcopal…3g
Claims (1)
身から寄生虫を駆除するにあたり、動物の体の一
部に次式(IA) (ここで、Xは塩素又は臭素原子を表わす) に相当する全ての可能な異性体形態にある化合物
の少なくとも1種を活性成分として、動物の処置
を可能にさせる適当なビヒクル中に含有する組成
物の有効量を投与することからなり、そして使用
する活性化合物の量を体重1Kg当たり0.5〜10mg
とすることを特徴とする、寄生虫のたかつた温血
動物(人を除く)から寄生虫を駆除する方法。 2 組成物を動物の背部の一部に投与することを
特徴とする特許請求の範囲第1項記載の方法。 3 活性化合物が(1R,cis)−2,2−ジメチ
ル−3−(2,2−ジクロル−1,2−ジブロム
エチル)シクロプロパン−1−カルボン酸(S)
α−シアノ−3−フエノキシベンジルであること
を特徴とする特許請求の範囲第1項記載の方法。 4 活性化合物が(1R,cis)−2,2−ジメチ
ル−3−(1,2,2,2−テトラブロムエチル)
シクロプロパン−1−カルボン酸(S)α−シア
ノ−3−フエノキシベンジルであることを特徴と
する特許請求の範囲第1項記載の方法。 5 皮膚層を通過できるようなビヒクルが分散性
化合物の油状溶液であることを特徴とする特許請
求の範囲第1〜3項いずれかに記載の方法。 6 分散性化合物がジメチルホルムアミド、ジメ
チルスルホキシド及びジメチルアセトアミドより
なる群から選ばれる物質であることを特徴とする
特許請求の範囲第4項記載の方法。 7 ビヒクルがジメチルホルムアミドの植物油溶
液であることを特徴とする特許請求の範囲第1〜
5項のいずれかに記載の方法。[Claims] 1. When exterminating parasites from the whole body of a warm-blooded animal (excluding humans) infected with parasites, the following formula (I A ) is applied to a part of the animal's body. (wherein X represents a chlorine or bromine atom) a composition containing as active ingredient at least one compound in all possible isomeric forms corresponding to and the amount of active compound used ranges from 0.5 to 10 mg/kg body weight.
A method for exterminating parasites from a warm-blooded animal (excluding humans) infested with parasites. 2. The method according to claim 1, wherein the composition is administered to a part of the back of the animal. 3 The active compound is (1R, cis)-2,2-dimethyl-3-(2,2-dichloro-1,2-dibromoethyl)cyclopropane-1-carboxylic acid (S)
The method according to claim 1, characterized in that it is α-cyano-3-phenoxybenzyl. 4 The active compound is (1R, cis)-2,2-dimethyl-3-(1,2,2,2-tetrabromoethyl)
The method according to claim 1, characterized in that cyclopropane-1-carboxylic acid (S) α-cyano-3-phenoxybenzyl. 5. A method according to any one of claims 1 to 3, characterized in that the vehicle capable of passing through the skin layers is an oily solution of the dispersible compound. 6. The method according to claim 4, wherein the dispersing compound is a substance selected from the group consisting of dimethylformamide, dimethylsulfoxide and dimethylacetamide. 7. Claims 1 to 7, characterized in that the vehicle is a solution of dimethylformamide in vegetable oil.
The method described in any of Section 5.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR7916892A FR2484256B1 (en) | 1979-06-29 | 1979-06-29 | METHOD FOR CONTROLLING PEST OF HOT BLOOD ANIMALS |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS568316A JPS568316A (en) | 1981-01-28 |
JPH0448775B2 true JPH0448775B2 (en) | 1992-08-07 |
Family
ID=9227301
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP8667580A Granted JPS568316A (en) | 1979-06-29 | 1980-06-27 | Novel composition for exterminating warmmblooded animal parasite |
Country Status (9)
Country | Link |
---|---|
JP (1) | JPS568316A (en) |
AU (1) | AU541208B2 (en) |
CH (1) | CH645023A5 (en) |
DE (1) | DE3024323A1 (en) |
FR (1) | FR2484256B1 (en) |
GB (1) | GB2052988B (en) |
NZ (1) | NZ194171A (en) |
OA (1) | OA06524A (en) |
ZA (1) | ZA803621B (en) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2471187A1 (en) * | 1979-12-10 | 1981-06-19 | Roussel Uclaf | NEW COMPOSITIONS FOR THE CONTROL OF PARASITES OF HOT-BLOOD ANIMALS |
HU182802B (en) * | 1980-02-26 | 1984-03-28 | Biogal Gyogyszergyar | Fotostabil delousing (insecticide) composition containing synthetic piretroides |
DE3208334A1 (en) * | 1982-03-09 | 1983-09-15 | Bayer Ag, 5090 Leverkusen | PESTICIDE POUR-ON FORMULATIONS |
NZ203574A (en) * | 1982-03-16 | 1986-04-11 | Wellcome Australia | Pour on compositions containing pyrethroids and thiazoles |
FR2555449B1 (en) * | 1983-11-25 | 1986-11-14 | Applipharm Ctre Rech Applic P | PYRETHROID COMPOSITION FOR THE LOCAL TREATMENT OF SKIN PARASITOSIS |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5340744A (en) * | 1976-09-21 | 1978-04-13 | Roussel Uclaf | Novel cyclopropane carboxylate containing polyhalogen substituent and agricultural chemical composition |
JPS5391127A (en) * | 1976-12-24 | 1978-08-10 | Wellcome Found | Animal medicine for exterminating harmful organism |
JPS53101340A (en) * | 1977-02-11 | 1978-09-04 | Ciba Geigy Ag | Cyclopropanecarboxylate * its preparation and preventing agent for harmful organism containing said compound |
JPS53104733A (en) * | 1976-12-24 | 1978-09-12 | Wellcome Found | Mite protecting composition |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NL180633C (en) * | 1973-06-22 | 1900-01-01 | Bayer Ag | PROCESS FOR PREPARING AN ANTHELMINTIC EFFECTIVE VETERINARY Pour-on Preparation. |
FR2398041A2 (en) * | 1977-07-19 | 1979-02-16 | Roussel Uclaf | CYCLOPROPANE CARBOXYLIC ACID ESTERS CONTAINING A POLYHALOGENIC SUBSTITUTE, PROCESS FOR PREPARATION AND THEIR APPLICATION AS INSECTICIDES, ACARICIDES, NEMATICIDES AND AS VETERINARY MEDICINAL PRODUCTS |
FR2419932A2 (en) * | 1978-03-17 | 1979-10-12 | Roussel Uclaf | NEW ESTERS OF CYCLOPROPANE CARBOXYLIC ACIDS CONTAINING A POLYHALOGENIC SUBSTITUTE, PREPARATION PROCESS AND INSECTICIDE COMPOSITIONS CONTAINING THEM |
FR2364884A1 (en) * | 1976-09-21 | 1978-04-14 | Roussel Uclaf | Fungicidal bactericidal cyclopropane carboxylic acid derivs. - are intermediates in prepn. of insecticidal, acaricidal, nematocidal and antifungal ester(s) |
DE2709264C3 (en) * | 1977-03-03 | 1982-01-21 | Bayer Ag, 5090 Leverkusen | Substituted phenoxybenzyloxycarbonyl derivatives, processes for their preparation and their use as insecticides and acaricides and new intermediates |
DE2730515A1 (en) * | 1977-07-06 | 1979-01-18 | Bayer Ag | SUBSTITUTED PHENOXYBENZYLOXYCARBONYL DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF AND THEIR USE AS INSECTICIDES AND ACARICIDES |
-
1979
- 1979-06-29 FR FR7916892A patent/FR2484256B1/en not_active Expired
-
1980
- 1980-04-29 OA OA57100A patent/OA06524A/en unknown
- 1980-06-17 ZA ZA00803621A patent/ZA803621B/en unknown
- 1980-06-27 JP JP8667580A patent/JPS568316A/en active Granted
- 1980-06-27 CH CH498180A patent/CH645023A5/en not_active IP Right Cessation
- 1980-06-27 GB GB8021250A patent/GB2052988B/en not_active Expired
- 1980-06-27 AU AU59736/80A patent/AU541208B2/en not_active Expired
- 1980-06-27 DE DE19803024323 patent/DE3024323A1/en active Granted
- 1980-06-27 NZ NZ194171A patent/NZ194171A/en unknown
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5340744A (en) * | 1976-09-21 | 1978-04-13 | Roussel Uclaf | Novel cyclopropane carboxylate containing polyhalogen substituent and agricultural chemical composition |
JPS5340743A (en) * | 1976-09-21 | 1978-04-13 | Roussel Uclaf | Novel cyclopropane carboxylate ester containing polyhalogen substituent process for preparing same and agriclutural chemical composition |
JPS5391127A (en) * | 1976-12-24 | 1978-08-10 | Wellcome Found | Animal medicine for exterminating harmful organism |
JPS53104733A (en) * | 1976-12-24 | 1978-09-12 | Wellcome Found | Mite protecting composition |
JPS53101340A (en) * | 1977-02-11 | 1978-09-04 | Ciba Geigy Ag | Cyclopropanecarboxylate * its preparation and preventing agent for harmful organism containing said compound |
Also Published As
Publication number | Publication date |
---|---|
AU5973680A (en) | 1981-01-08 |
ZA803621B (en) | 1982-01-27 |
DE3024323C2 (en) | 1991-04-25 |
GB2052988B (en) | 1983-04-07 |
GB2052988A (en) | 1981-02-04 |
CH645023A5 (en) | 1984-09-14 |
AU541208B2 (en) | 1984-12-20 |
FR2484256A1 (en) | 1981-12-18 |
OA06524A (en) | 1981-07-31 |
FR2484256B1 (en) | 1986-10-24 |
NZ194171A (en) | 1985-01-31 |
DE3024323A1 (en) | 1981-01-22 |
JPS568316A (en) | 1981-01-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2018065880A5 (en) | ||
US4973589A (en) | Method of preventing the reinfestation of dogs and cats by fleas | |
US5169846A (en) | Non-aqueous micellar solutions of anthelmintic benzimidazoles, closantel, or phenothiazine, and insect growth regulators | |
JP2978245B2 (en) | Parasite control composition and its production and use | |
JP2015091843A (en) | Compositions for enhanced acaricidal activity | |
HU200697B (en) | Process for producing compositions against ectoparasites, not having skin irratating effect on body-surface of animals, as well as pesticides | |
NZ195796A (en) | Pesticidal compositions containing carboxylic acid derivatives | |
EP0616494B1 (en) | 1- n-(halo-3-pyridylmethyl)]-n-methylamino-1-alkylamino-2-nitroethylene derivatives for use against fleas on pets | |
JPH0448775B2 (en) | ||
JPH0222041B2 (en) | ||
DE69732703T2 (en) | METHOD AND COMPOSITION FOR ANTIPARASITIC TREATMENT OF THE ENVIRONMENT OF ANIMALS | |
JPS5942647B2 (en) | Acaricidal composition | |
JPH0347250B2 (en) | ||
HU206037B (en) | Process for producing nonaqueous pharmaceutical compositions for external use | |
US5006545A (en) | Veterinary compositions against endoparasites containing cypermethrin and albendazole | |
US3179557A (en) | N-methyl-phenyl carbamates for controlling animal pests | |
US4826874A (en) | Use of pyrethroids in a pour-on parasitic method | |
DE2458464C2 (en) | ||
JP2001139403A (en) | Expellant of ectoparasite for animal | |
JP2003095813A (en) | Liquid agent for expelling exoparasite of animal | |
JPH08225417A (en) | Aerosol agent for controlling house tick | |
EP0112602B1 (en) | Eradication of mites | |
JP2001503034A (en) | How to prevent reinfestation of warm-blooded animals by ectoparasites | |
JPH08208413A (en) | Aerosolagent for controlling interior mite | |
US20020040027A1 (en) | Method for the prevention of the reinfestation of warm-blooded animals by ectoparasites |